Insulin Glargine/Lixisenatide

Brand name: Soliqua 100-33

Rank #170 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$92.5M

Total Cost

Share:

82,886

Total Claims

$92.5M

Total Cost

2,854

Prescribers

$1,116

Cost per Claim

9,518

Beneficiaries

135,096

30-Day Fills

$32K

Avg Cost/Provider

29

Avg Claims/Provider

Share of Medicare Part D Spending

0.03%

of total Medicare Part D spending

$92.5M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $92.5M total

🔎 Data Overview

💰

At $1,116 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.

👤

Average cost of $9,714 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Insulin Glargine/Lixisenatide

#ProviderSpecialtyLocationClaimsCost
1Marcelo BendixInternal MedicineMiami, FL621$683K
2Tom ThomasEndocrinologyPasadena, TX557$596K
3Kristen RiderNurse PractitionerFestus, MO420$501K
4Mark JohnsonEndocrinologyMason City, IA362$362K
5Lee MetchickEndocrinologyDeland, FL214$356K
6Laura OlsonNurse PractitionerLas Vegas, NV279$354K
7Miguel PariloEndocrinologyDayton, OH279$321K
8Linda BartonNurse PractitionerAsheville, NC285$306K
9Carlos Martinez RiveraEndocrinologyMayaguez, PR301$292K
10Selby RouchPhysician AssistantWinston Salem, NC191$288K
11Nawras MakhsidaEndocrinologyRandolph, NJ254$275K
12John PalmerEndocrinologyRapid City, SD195$272K
13Lyle MyersEndocrinologyLexington, KY188$258K
14Daniel SoEndocrinologyArlington Heights, IL140$248K
15Jimmy NguyenPharmacistPalm Springs, CA247$246K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
167Sevelamer Carbonate (Sevelamer Carbonate)$95.6M277,192
168Aripiprazole Lauroxil (Aristada)$93.3M31,120
169Trazodone Hcl (Trazodone Hcl)$92.6M7,273,528
170Insulin Glargine/Lixisenatide (Soliqua 100-33)$92.5M82,886
171Latanoprost (Latanoprost)$92.3M4,388,601
172Ribociclib Succinate (Kisqali)$90.3M5,978
173Lacosamide (Lacosamide)$90.1M300,038

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology